Regeneron Pharmaceuticals Market Sentiment

Regeneron Pharmaceuticals Inc

REGNNASDAQ

Trade with Public

$788.04

-7.98-1%

가까이에: Sep 25, 5:00 PM EST

$788.04

N/A

시간외: Sep 25, 4:35 PM EST

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 배당금 비교 옵션 주식 보고서

Regeneron Pharmaceuticals Market Sentiment

Market sentiment signals for Regeneron Pharmaceuticals (REGN): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 2.6% short float

Options Flow▼ 1.23 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

31 analysts

Options Flow (P/C)

1.23

More puts — Bearish

271 calls · 333 puts

Avg Consensus PT

$798

+1.3%

Highest Price Target

$1030

+30.7%

Guggenheim

Lowest Price Target

$185

-76.5%

Benchmark

Short Interest

2.6%

Declining — Bullish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 10, 2026	HSBC	Rajesh Kumar—	+16.7%	$800 → $920	Maintained	Buy
Aug 17, 2026	Leerink Partners	David Risinger—	+4.6%	$641 → $824	Maintained	Market Perform
Aug 3, 2026	Citigroup	Geoff Meacham—	-6.1%	$700 → $740	Maintained	Neutral
Aug 3, 2026	Guggenheim	Brad Canino—	+30.7%	$1000 → $1030	Maintained	Buy
Jul 31, 2026	RBC Capital	Brian Abrahams—	-6.5%	$696 → $737	Maintained	Sector Perform
Jul 31, 2026	Morgan Stanley	Matthew Harrison—	-3.8%	$730 → $758	Maintained	Equal-Weight
Jul 31, 2026	Cantor Fitzgerald	Carter Gould—	+0.9%	$750 → $795	Maintained	Overweight
Jul 31, 2026	Wells Fargo	Mohit Bansal—	-4.8%	$700 → $750	Maintained	Equal-Weight
Jul 31, 2026	Truist Securities	Gregory Renza—	-2.0%	$769 → $772	Maintained	Buy
Jul 21, 2026	Guggenheim	Brad Canino—	+26.9%	$995 → $1000	Maintained	Buy
Jul 9, 2026	Piper Sandler	Biren Amin—	+8.4%	$855 → $854	Maintained	Overweight
Jul 8, 2026	Morgan Stanley	Matthew Harrison—	-7.4%	$788 → $730	Maintained	Equal-Weight
Jul 7, 2026	RBC Capital	Brian Abrahams—	-11.7%	$707 → $696	Maintained	Sector Perform
Jul 7, 2026	Truist Securities	Gregory Renza—	-2.4%	$778 → $769	Maintained	Buy
Jul 7, 2026	Benchmark	Robert Wasserman—	-76.5%	$185	Upgrade	Hold→Buy
Jul 6, 2026	HSBC	Rajesh Kumar—	+11.7%	$990 → $880	Maintained	Buy
Jul 6, 2026	Cantor Fitzgerald	Carter Gould—	-4.8%	$785 → $750	Maintained	Overweight
May 19, 2026	Canaccord Genuity	John Newman—	+11.0%	$1057 → $875	Maintained	Buy
May 18, 2026	BMO Capital	Evan David Seigerman—	-7.4%	$900 → $730	Maintained	Outperform
May 18, 2026	Truist Securities	Gregory Renza—	-1.3%	$796 → $778	Maintained	Buy
May 18, 2026	JP Morgan	Chris Schott—	+7.9%	$950 → $850	Maintained	Overweight
May 18, 2026	Piper Sandler	Biren Amin—	+8.5%	$875 → $855	Maintained	Overweight
May 18, 2026	Wells Fargo	Mohit Bansal—	-11.2%	$800 → $700	Maintained	Equal-Weight
May 18, 2026	RBC Capital	Brian Abrahams—	-10.3%	$762 → $707	Maintained	Sector Perform
May 18, 2026	Citigroup	Geoff Meacham—	-11.2%	$900 → $700	Downgrade	Buy→Neutral